Get the Stockscreener App
21.51
3.97%
-0.89
Tectonic Therapeutic Inc stock is traded at $21.51, with a volume of 110.34K.
It is down -3.97% in the last 24 hours and up +6.35% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$22.40
Open:
$22.17
24h Volume:
110.34K
Relative Volume:
0.53
Market Cap:
$401.59M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.65%
1M Performance:
+6.35%
6M Performance:
-56.79%
1Y Performance:
+0.00%
1-Day Range:
$21.08
$22.20
1-Week Range:
$21.08
$22.75
52-Week Range:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
21.51 | 404.26M | 0 | 0 | 0 | 0.00 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Northern Trust Corp Raises Stock Holdings in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Reports Q1 2025 Financial Results - TipRanks
Tectonic, Tenax, others aim for shift in heart failure - BioWorld MedTech
29,702 Shares in Tectonic Therapeutic (NASDAQ:TECX) Purchased by Jane Street Group LLC - Defense World
Tectonic Therapeutic Announces Phase 1b Trial Results - TipRanks
Tectonic Therapeutic Presents Complete Results for Positive - GlobeNewswire
Quant Signal Points to a Possible Earnings Surprise for Baidu (BIDU) - The Globe and Mail
Could Buying Amazon Today Set You Up for Life? - The Globe and Mail
Tectonic Phase 1b Trial Shows 30% Improvement in Key Heart Failure Metrics | TECX Stock News - Stock Titan
Mizuho Increases Tectonic Therapeutic (NASDAQ:TECX) Price Target to $85.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Receives $72.40 Average Target Price from Analysts - Defense World
Dimensional Fund Advisors LP Boosts Holdings in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Wall Street Analysts See a 258.52% Upside in Tectonic Therapeutic, Inc. (TECX): Can the Stock Really Move This High? - MSN
Why Intuitive Machines Stock Is Going to the Moon Today - The Globe and Mail
Raymond James Financial Inc. Takes Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
2 Soaring Stocks That Have Room to Run - The Globe and Mail
Tectonic Therapeutic Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference - GlobeNewswire
Tectonic Therapeutic (NASDAQ:TECX) Shares Purchased by Barclays PLC - Defense World
Tectonic Therapeutic Inc expected to post a loss of $1.09 a shareEarnings Preview - TradingView
Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic - Yahoo Finance
3 High-Growth Tech Stocks That Are Screaming Buys in May - The Globe and Mail
Tectonic Therapeutic (NASDAQ:TECX) Shares Sold by Wells Fargo & Company MN - Defense World
Geode Capital Management LLC Grows Stock Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
How did Tectonic Therapeutic Inc (TECX) fare last session? - uspostnews.com
Tectonic Announces $185 Million Private Placement - The Globe and Mail
TECXTectonic Therapeutic Inc Latest Stock News & Market Updates - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Receives Average Rating of “Buy” from Brokerages - The AM Reporter
Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Mizuho - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Increase in Short Interest - Defense World
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $77.75 - Defense World
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Mizuho Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform Recommendation - Nasdaq
Mizuho Initiates Tectonic Therapeutic at Outperform - marketscreener.com
Mizuho sets Tectonic stock Outperform with $51 target - Investing.com Australia
Mizuho sets Tectonic stock Outperform with $51 target By Investing.com - Investing.com India
Tectonic Therapeutic Inc (NASDAQ: TECX): Blank Check For Growth? - Stocksregister
Vanguard Group Inc. Has $16.67 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic To Present Phase 1B Data For Tx45 At European Society Of Cardiology Heart Failure 2025 - marketscreener.com
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025 - GlobeNewswire
Major Breakthrough: New Phase 1b Heart Failure Drug Data Promises Key Insights at ESC 2025 - Stock Titan
Tectonic Therapeutic Insider Bought Shares Worth $2,299,015, According to a Recent SEC Filing - marketscreener.com
Tectonic Therapeutic director Timothy Springer acquires $2.3 million in shares By Investing.com - Investing.com South Africa
Major Investment Alert: Insider Buys Big in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic director Timothy Springer acquires $2.3 million in shares - Investing.com
Commonwealth Equity Services LLC Takes $231,000 Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Tectonic Therapeutic Inc Stock (TECX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
45,858 |
767,204 |
1,449,652 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
21,071 |
311,020 |
1,403,794 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
16.31 |
9,478 |
154,586 |
4,334,846 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
8,092 |
135,379 |
4,325,368 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
3,718 |
54,880 |
4,317,276 |
| SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
412,500 |
7,053,750 |
1,382,723 |
| SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
87,500 |
1,496,250 |
4,313,558 |
| MCGUIRE TERRANCE | Director |
Apr 07 '25 |
Sale |
17.10 |
500,000 |
8,550,000 |
573,062 |
| SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
50.00 |
660,000 |
33,000,000 |
970,223 |
| SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
54.14 |
129,294 |
6,999,977 |
4,226,058 |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):